Dr. Martens (DOCS) Stock Chart & Stock Price History GBX 66.20 -0.05 (-0.07%) As of 02/21/2025 12:45 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider Trades Dr. Martens Stock Price Performance 5 Day Performance-7.30%1 Month Performance-8.06%3 Month Performance+17.38%6 Month Performance-11.61%Year-To-Date Performance-8.31%1 Year Performance-32.24% Receive DOCS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock Chart for Saturday, February, 22, 2025 DOCS Chart by TradingView Dr. Martens Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025GBX 66.74GBX 66.20-0.81%GBX 67.25GBX 65.40428,912 shs£642.66 million02/20/2025GBX 66.80GBX 66.74-0.09%GBX 68.05GBX 65.70654,186 shs£647.91 million02/19/2025GBX 70.46GBX 66.80-5.20%GBX 73.85GBX 66.801.01 million shs£648.47 million02/18/2025GBX 71.41GBX 70.46-1.33%GBX 74.65GBX 70.10625,773 shs£684.01 million02/17/2025GBX 72GBX 71.41-0.81%GBX 75.60GBX 71.05636,165 shs£693.23 million02/14/2025GBX 72.03GBX 72-0.05%GBX 73.25GBX 71.601.44 million shs£698.90 million02/13/2025GBX 72.01GBX 72.03+0.03%GBX 72.75GBX 71815,699 shs£699.25 million02/12/2025GBX 71.71GBX 72.01+0.42%GBX 72.95GBX 70.85929,960 shs£692.54 million02/11/2025GBX 71.56GBX 71.71+0.21%GBX 72.60GBX 71.30595,991 shs£689.63 million02/10/2025GBX 73.18GBX 71.56-2.22%GBX 73GBX 71.301.18 million shs£688.19 million Get the Latest News and Ratings for DOCS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025GBX 74.65GBX 73.18-1.97%GBX 76.05GBX 72.751.04 million shs£703.78 million02/06/2025GBX 73.26GBX 74.65+1.89%GBX 76GBX 70.701.66 million shs£717.89 million02/05/2025GBX 71.74GBX 73.26+2.11%GBX 73.65GBX 69.852.72 million shs£704.54 million02/04/2025GBX 70.73GBX 71.74+1.43%GBX 72.41GBX 701.04 million shs£689.97 million02/03/2025GBX 72.45GBX 70.73-2.38%GBX 71.40GBX 69.701.48 million shs£680.22 million01/31/2025GBX 72.03GBX 72.45+0.58%GBX 73.60GBX 71.902.28 million shs£696.77 million01/30/2025GBX 70.47GBX 72.03+2.21%GBX 72.70GBX 66.651.39 million shs£692.76 million01/29/2025GBX 71.76GBX 70.47-1.80%GBX 73.25GBX 69.75824,255 shs£677.75 million01/28/2025GBX 71.30GBX 71.76+0.65%GBX 73.70GBX 69.241.10 million shs£690.15 million01/27/2025GBX 72.71GBX 71.30-1.93%GBX 73.05GBX 69.9582.84 million shs£685.71 million01/24/2025GBX 70.90GBX 72.71+2.55%GBX 74.27GBX 68.551.41 million shs£699.22 million01/23/2025GBX 72GBX 70.90-1.53%GBX 72.15GBX 68.901.25 million shs£681.86 million01/22/2025GBX 70.48GBX 72+2.16%GBX 72.85GBX 67.75929,353 shs£692.46 million01/21/2025GBX 68.50GBX 70.48+2.89%GBX 71GBX 67.75644,107 shs£677.79 million Related Companies Vistry Group Stock Price Chart Templeton Emerging Markets Investment Trust Stock Price Chart Spirent Communications Stock Price Chart Genuit Group Stock Price Chart YouGov Stock Price Chart Wickes Group Stock Price Chart Scottish Oriental Smaller Cos Stock Price Chart Netcall Stock Price Chart Stelrad Group Stock Price Chart Arbuthnot Banking Group Stock Price Chart Receive DOCS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DOCS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
